The team at Freshfields Bruckhaus Deringer LLP assists high-profile multinationals across a range of industries including life sciences and technology with a vast array of matters, but particularly M&A deals with critical tax elements. Based out of New York, Steven Matays leads the practice, with significant experience representing clients on a wide range of international tax matters, with a particular emphasis on mergers and acquisitions, spin-offs, and other divestitures. Based in Washington DC, Claude Stansbury advises a client roster formed of multinational companies, private equity funds, and financial advisors on cross-border acquisitions, financings, restructurings, and disposals. Stansbury also holds significant experience in advising financial institutions and large multinational clients on financial products and derivatives. Joe Soltis, based in New York, is a key contact handling both private and public M&A tax advice. Sarah Katz joined the team in 2024 from Paul, Weiss, Rifkind, Wharton & Garrison LLP.
Legal 500 Editorial commentary

Key clients

  • Sanofi
  • Johnson & Johnson
  • Executive Chairman of Endeavor
  • Roivant Sciences
  • AstraZeneca
  • Special Committee of PowerSchool Holdings
  • Cinven
  • Cencora
  • Sonoco Products Company
  • Zeus Company

Work highlights

  • Advised Sanofi on its exclusive negotiations with CD&R for the potential purchase and sale of a 50% controlling stake in Opella.
  • Advised Johnson & Johnson on the tax aspects of its $13.1bn acquisition of Shockwave Medical.
  • Advised the Executive Chairman of Endeavor, in connection with the company’s pending sale to Silver Lake. Silver Lake will acquire Endeavor at an equity value of $13 billion.

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Steven Matays

Other key lawyers

Claude Stansbury; Joe Soltis; Sarah Katz